Trial Profile
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2018
Price :
$35
*
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Fissure in ano
- Focus Pharmacokinetics
- Sponsors Adare Pharmaceuticals; Forest Laboratories
- 07 May 2015 New trial record